Mirae Asset Global ETFs Holdings’s Maravai LifeSciences MRVI Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Buy	165,069 +42,909	+35%	+$185K	﹤0.01%	1615
2026 Q1	$346K	Buy	122,160 +4,932	+4%	+$16.7K	﹤0.01%	2075
2025 Q4	$381K	Sell	117,228 -10,949	-9%	-$36.9K	﹤0.01%	2028
2025 Q3	$368K	Sell	128,177 -18,379	-13%	-$46.9K	﹤0.01%	2018
2025 Q2	$353K	Sell	146,556 -94,480	-39%	-$199K	﹤0.01%	1991
2025 Q1	$533K	Sell	241,036 -7,730	-3%	-$30.5K	﹤0.01%	1836
2024 Q4	$1.36M	Buy	248,766 +188,163	+310%	+$1.21M	﹤0.01%	1377
2024 Q3	$504K	Buy	+60,603	New	+$524K	﹤0.01%	1907

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MRVI Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Maravai LifeSciences (MRVI) stake by 35% in Q2 2026, buying an estimated $185K and bringing the position to 165,069 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1615.

Mirae Asset Global ETFs Holdings first reported a position in MRVI in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.36M in Q4 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Mirae Asset Global ETFs Holdings held 165,069 shares of Maravai LifeSciences worth $1.03M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 42,909 Maravai LifeSciences shares in Q2 2026, an estimated $185K.
Maravai LifeSciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1615 holding.
Mirae Asset Global ETFs Holdings first reported a position in Maravai LifeSciences in Q3 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Maravai LifeSciences position peaked at $1.36M in Q4 2024.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.